Loading company…
Rehydration Therapeutics develops small nucleic acid treatments with targeted delivery to tissues outside the liver.
Rehydration Therapeutics develops small nucleic acid therapeutics, with a focus on targeted delivery to extrahepatic tissues. Its research includes potential treatments for eye conditions and an AI-assisted platform for screening targeting molecules. Founded in 2024, the company is based in Shanghai, China. In May 2026, it closed an angel+ funding round led by 3E Bioventures Capital, with participation from Furong Capital and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in